Prostate Cancer Utilities and Cost-Effectiveness Analysis
The goal of this project is to incorporate patients' preferences into a previously developed
prostate cancer treatment decision-model and to understand the implications for doing so for
cost-effectiveness analysis. To do this, it is first necessary to obtain patient utility
scores (i.e., patient preference weights). To do this we will perform a survey of patients
visiting the urology clinic to undergo prostate biopsies to validate a method of utility
assessment, and understand the patients' individual evaluations of treatment-related health
studies. We will also ask patients questions relating to their anxiety levels concerning the
possible diagnosis of prostate cancer.
Observational Model: Cohort, Time Perspective: Prospective
Utility scores for treatment outcomes
Patient utility scores (i.e. patient preference weights) are calculated using survery data will determine which prostate cancer treatment would be most cost-effective for each subject. Patients will be contacted by phone and patient records will be reviewed 90 days after the survey has been completed to determine whether this data reflects actual treatment decisions.
90 days after enrollment
David Meltzer, M.D., Ph.D.
University of Chicago
United States: Institutional Review Board
|The University of Chicago||Chicago, Illinois 60637|